Modulation of doxorubicin cytotoxicity by resveratrol in a human breast cancer cell line

被引:0
作者
Abdel-Moneim M Osman
Hadeel M Bayoumi
Sameer E Al-Harthi
Zoheir A Damanhouri
Mohamed F ElShal
机构
[1] King Abdul-Aziz University,Department of Pharmacology, Faculty of Medicine
[2] King Abdul-Aziz University,Depatment of Biochemistry, Faculty of Science
来源
Cancer Cell International | / 12卷
关键词
Doxorubicin; Resveratrol; Breast cancer cell line;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 148 条
[1]  
Najjar H(2010)Age at diagnosis of breast cancer in Arab nations Int J Surg 8 448-452
[2]  
Easson A(1992)The anthracyclines: will we ever find a better doxorubicin? Semin Oncol 19 670-686
[3]  
Weiss RB(1973)A clinicopathologic analysis of adriamycin cardiotoxicity Cancer 32 302-314
[4]  
Lefrak EA(2009)Resveratrol and chemoprevention Cancer Lett 284 1-6
[5]  
Pitha J(2003)Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities Curr Med Chem Anticancer Agents 3 77-93
[6]  
Rosenheim S(2007)Resveratrol: a review of preclinical studies for human cancer prevention Toxicol Appl Pharmacol 224 274-283
[7]  
Gottlieb JA(2004)Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies Anticancer Res 24 2783-2840
[8]  
Goswami SK(1990)New colorimetric cytotoxicity assay for anticancer-drug screening J Natl Cancer Inst 82 1107-1112
[9]  
Das DK(1998)Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure Cytometry 31 1-9
[10]  
Cal C(2004)Analysis of Cell Cycle by Flow Cytometry Methods Mol.Biol 281 301-311